(function(){
			var content_array=["<p><b>关于<\/b><b>TVM Capital Life Science <\/b><\/p> \n<p>TVM Capital Life Science为北美和欧盟的国际生物制药、医疗技术和诊断公司提供风险投资。TVM采用双管齐下的策略，主要关注早期和晚期投资。<\/p> \n<p><a target=\"_blank\" href=\"https:\/\/t.prnasia.com\/t\/8mFf6gCx\" rel=\"nofollow\">www.tvm-lifescience.com<\/a><\/p> \n<p><b>联系人：<\/b>&nbsp;<\/p> \n<p>媒体\/新闻：<br \/><b>TVM Capital Life Science<\/b><b>：<\/b>&nbsp;Stefan Fischer，执行合伙人（融资）, TVM Capital Life Science，<a target=\"_blank\" href=\"https:\/\/t.prnasia.com\/t\/tUBDKhS1\" rel=\"nofollow\">fischer@tvm-capital.com<\/a>，+49 89 998 992 36<\/p> \n<p>投资者：<br \/><b>OCP Capital<\/b><b>：<\/b>创始人Joelle Wyser-Pratte<a target=\"_blank\" href=\"https:\/\/t.prnasia.com\/t\/4vLuXxEf\" rel=\"nofollow\">joelle@ocpcap.com<\/a>，+1 914 441 3554<\/p> \n<p><b>普通合伙人<\/b>&nbsp;<br \/>TVM Life Science Innovation II (GP) S. &agrave; r.l. <br \/>8, Rue Lou Hemmer <br \/>L-1748, Senningerberg <br \/>Grand Duchy of <span class=\"xn-location\">Luxembourg<\/span> <\/p> \n<p>投资顾问<br \/>TVM Life Science Management Inc. <br \/>2 Place Alexis Nihon, Suite 902, Montr&eacute;al, QC H3Z 1X5, <span class=\"xn-location\">Canada<\/span> <\/p> \n<p>TVM Life Science Management GmbH <br \/>Ottostrasse 4 <br \/>80333 <span class=\"xn-location\">Munich<\/span> <br \/><span class=\"xn-location\">Germany<\/span><\/p> \n<p>标志&nbsp;- <a target=\"_blank\" href=\"https:\/\/mma.prnasia.com\/media2\/1319854\/TVM_Capital_Life_Science_Logo.jpg?p=medium600\" rel=\"nofollow\">https:\/\/mma.prnasia.com\/media2\/1319854\/TVM_Capital_Life_Science_Logo.jpg?p=medium600<\/a><\/p>"];
			$("#dvExtra").html(content_array[0]);})();